- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Myeloid Leukemia in Canada
Total 870 results
-
Janssen Research & Development, LLCApproved for marketingMultiple MyelomaUnited States, United Kingdom, Spain, Brazil, Russian Federation, Japan
-
AbbVieJanssen Research & Development, LLCActive, not recruitingMultiple MyelomaUnited States, Australia, Canada, Denmark, France, Germany, Japan
-
PETHEMA FoundationCompleted
-
PfizerActive, not recruitingMultiple MyelomaUnited States, Canada, Spain, Belgium, United Kingdom, Australia, Japan, France, Germany, Poland
-
CelgeneCompletedMultiple MyelomaCanada, Denmark, Australia, Belgium, France, Germany, Italy, Netherlands, Russian Federation, Spain, Sweden, Switzerland, United Kingdom, Czechia, Greece
-
PETHEMA FoundationCompleted
-
GlaxoSmithKlineRecruitingMultiple MyelomaUnited States, Australia, France, Japan, Netherlands, Poland, Spain, Sweden, Greece, Canada, Korea, Republic of, Germany, Brazil, Israel, Mexico, Norway, Russian Federation
-
Bristol-Myers SquibbAbbVieCompletedMultiple MyelomaUnited States, Italy, Spain, France, Canada
-
Janssen Research & Development, LLCActive, not recruitingHematological MalignanciesCanada, United States, France, Italy, United Kingdom, Germany, Belgium, Netherlands, Spain, Sweden, China
-
Celgene CorporationPrologue Research InternationalCompletedMultiple MyelomaUnited States, Canada
-
Multiple Myeloma Research FoundationSpectrum Health Hospitals; Translational Genomics Research Institute; Van Andel...CompletedMultiple MyelomaUnited States, Spain, Canada
-
AEterna ZentarisDana-Farber Cancer InstituteTerminatedMultiple MyelomaIsrael, Spain, Korea, Republic of, United States, Russian Federation, Canada, Ireland, Czechia, Slovakia
-
Millennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States, Canada, Spain, Israel, United Kingdom, Germany, Austria, Belgium, France, Italy, Ireland, Netherlands, Sweden
-
Janssen Research & Development, LLCTerminatedAsymptomatic Amyloid-positiveUnited States, Canada, United Kingdom, Belgium, Germany, Spain, Japan, Australia, Netherlands, Denmark, Mexico, Finland, Sweden
-
Janssen Research & Development, LLCRecruitingMultiple MyelomaBelgium, Korea, Republic of, Australia, United Kingdom, France, Sweden, Spain, Turkey, Italy, Czechia, Netherlands, Poland, Switzerland, Germany
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaCanada, United States, Belgium, Korea, Republic of, United Kingdom, Sweden, Italy, Denmark, Japan, Taiwan, China, Germany, Spain, France, Netherlands, Turkey, Russian Federation, Poland, Greece, Argentina, Brazil
-
Janssen Research & Development, LLCTerminatedMultiple MyelomaCanada, United States, Belgium, Poland, Italy, France, Spain, Brazil, Russian Federation, Denmark, Greece, Germany, Netherlands
-
PfizerRecruitingMultiple MyelomaJapan, Taiwan, Canada, Spain, Australia, Italy, Czechia, Korea, Republic of, France, Greece, Israel, Poland, Germany
-
Stichting European Myeloma NetworkJanssen Research & Development, LLCRecruitingMultiple MyelomaNetherlands, United States, Spain, Belgium, France, Italy, Germany, Japan, Canada, Australia, Sweden, Israel, United Kingdom, Czechia, Greece, Switzerland, Norway
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Australia, Canada, France, Germany, Israel, Italy, Japan, Netherlands, Spain, United Kingdom
-
CelgeneCompletedMultiple MyelomaUnited States, Netherlands, Canada, Belgium, United Kingdom, Australia, Denmark, Germany, Spain, Switzerland, France, Italy, Greece, Russian Federation, Sweden, Czechia
-
Janssen Research & Development, LLCCompletedMultiple MyelomaUnited States, France, Poland, United Kingdom, Belgium, Spain, Germany, Portugal, Bulgaria, Romania, Netherlands, Greece, Canada, Russian Federation, Hungary, Brazil, Slovakia, Czechia
-
Celgene CorporationCompletedMultiple MyelomaUnited States, Spain, Australia, Canada, United Kingdom, Italy, Switzerland, Bulgaria, Poland, Ukraine, Belgium, Germany, Hungary, Ireland, Israel, Russian Federation
-
pharmaand GmbHCompletedMultiple MyelomaCanada, Spain, United States, Czechia, Turkey, France, Sweden, Korea, Republic of, Thailand, Belgium, Greece, Germany, Hungary, Russian Federation, Italy, Poland, Australia, Lebanon, Portugal, Norway, Brazil, Netherlands
-
Bristol-Myers SquibbRecruitingMultiple MyelomaCanada, Taiwan, United States, Australia, Denmark, China, Korea, Republic of, Israel, Spain, France, Germany, Czechia, Austria, Japan, Sweden, United Kingdom, Greece, Italy, Finland, Argentina, Belgium, Brazil, Colombia, Hong Kong, India, Mexic... and more
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaCanada, United States, Israel, Czechia, Turkey, Germany, United Kingdom, Japan, Netherlands, France, Brazil, Poland, Spain
-
Janssen Research & Development, LLCRecruitingMultiple MyelomaUnited States, Korea, Republic of, Denmark, Czechia, Israel, Switzerland, Belgium, United Kingdom, Japan, Argentina, Sweden, Canada, Spain, Germany, Netherlands, France, Brazil, Greece, Poland, Ireland, Hungary, Portugal, Australia, F... and more
-
CelgeneCompletedMultiple MyelomaFrance, Italy, Spain, Belgium, Greece
-
GlaxoSmithKlineActive, not recruitingMultiple MyelomaUnited States, Australia, Spain, Bulgaria, Poland, Belgium, France, Germany, Italy, Hungary, United Kingdom, Greece, Russian Federation, Brazil, China, Korea, Republic of, Japan, Canada, Netherlands
-
TakedaActive, not recruitingMultiple MyelomaUnited States, Spain, Canada, Korea, Republic of, Taiwan, China, Italy, Germany, Israel, France, United Kingdom, Greece, Japan, Norway, Puerto Rico, Turkey
-
GlaxoSmithKlineRecruitingMultiple MyelomaUnited States, Italy, Poland, Spain, Taiwan, Brazil, Greece, Ireland, Mexico, Canada, Korea, Republic of, Germany, France, Australia, United Kingdom, Argentina, India, Thailand, Switzerland
-
Bristol-Myers SquibbRecruitingMultiple MyelomaUnited States, Canada, France, Germany, Italy, United Kingdom
-
AmgenDaiichi Sankyo, Inc.CompletedCancer | Multiple Myeloma | Bone Metastases | Hematologic Malignancies | Oncology | Multiple Myeloma Bone LesionsUnited States, Germany, Italy, Spain, Canada, France, Czechia, Hungary, Korea, Republic of, Russian Federation, United Kingdom, Taiwan, Australia, Hong Kong, New Zealand, Austria, Slovakia, Portugal, Greece, Bulgaria, Poland, Ukraine and more
-
Bristol-Myers SquibbAbbVieCompletedMultiple MyelomaCanada, United States, Israel, Czechia, Switzerland, Greece, Denmark, Portugal, Italy, Germany, Austria, Norway, Puerto Rico, Spain, Sweden, Turkey
-
Janssen Research & Development, LLCCompletedMultiple MyelomaAustralia, France, Poland, United Kingdom, United States, Spain, Israel, Portugal, South Africa, Canada, Netherlands, Belgium, Singapore, Russian Federation, Czech Republic, Argentina, Austria
-
AmgenCompletedMultiple MyelomaCanada, Denmark, Finland, France, Italy, Spain, Sweden, United Kingdom, Czechia, Poland, United States, Belgium, Hungary, New Zealand, Australia, Germany, Japan, Greece, Norway, Romania
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaUnited States, Australia, France, Poland, United Kingdom, Belgium, Germany, Taiwan, Spain, Israel, Japan, Canada, Netherlands, Denmark, Sweden, Korea, Republic of, Russian Federation, Greece
-
GlaxoSmithKlineActive, not recruitingMultiple MyelomaAustralia, Japan, Spain, Germany, Poland, Belgium, Israel, Italy, Russian Federation, Canada, New Zealand, Korea, Republic of, China, Brazil, Czechia, United States, Netherlands, United Kingdom, Greece, France
-
Karyopharm Therapeutics IncActive, not recruitingMultiple MyelomaUnited States, United Kingdom, Australia, Israel, Canada, Belgium, Austria, Czechia, Serbia, India, France, Italy, Russian Federation, Bulgaria, Germany, Greece, Hungary, Poland, Romania, Spain, Ukraine
-
CelgeneBristol-Myers SquibbRecruitingMultiple MyelomaAustria, United States, Spain, Australia, Japan, France, Israel, Italy, Canada, Greece, Belgium, Norway, Romania, Czechia, Denmark, Germany, Korea, Republic of, United Kingdom, Poland
-
CelgeneBristol-Myers SquibbRecruitingMultiple MyelomaAustria, United States, Spain, Australia, Japan, France, Israel, Italy, Canada, Greece, Belgium, Norway, Romania, Czechia, Denmark, Germany, Korea, Republic of, United Kingdom, Poland
-
Millennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States, France, Korea, Republic of, Canada, Belgium, New Zealand, Russian Federation
-
Millennium Pharmaceuticals, Inc.CompletedMultiple MyelomaUnited States, United Kingdom, Canada, Israel, France, Austria, Belgium, Germany, Ireland, Italy, Netherlands, Spain, Sweden
-
Eisai Inc.National Institute on Aging (NIA); Biogen; Alzheimer's Clinical Trials ConsortiumRecruitingPreclinical Alzheimer's Disease | Early Preclinical Alzheimer's DiseaseUnited States, Singapore, Canada, Spain, Australia, Japan, United Kingdom, Sweden, Netherlands
-
TakedaCompletedMultiple MyelomaUnited States, Spain, United Kingdom, Belgium, Taiwan, Italy, Israel, China, Turkey, Germany, Greece, Mexico, Colombia, France, Brazil
-
Bristol-Myers SquibbAbbVieCompletedMultiple MyelomaUnited States, Australia, Austria, Belgium, Canada, Czechia, Germany, Greece, Hungary, Ireland, Israel, Italy, Poland, Puerto Rico, Romania, Russian Federation, Spain, Switzerland, Turkey, United Kingdom
-
CelgeneTerminatedMultiple MyelomaSpain
-
CelgeneCompletedMultiple MyelomaUnited States, Spain, United Kingdom, Italy, Israel, Portugal, Germany, Turkey, Greece, Ireland, Austria, Norway, Netherlands, Denmark, Poland, France, Russian Federation, Canada, Finland, Japan, Puerto Rico, Sweden
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaUnited States, France, United Kingdom, Belgium, Germany, Israel, Australia, Sweden, Canada, Netherlands, Austria, Ireland, Denmark
-
AmgenCompletedMultiple MyelomaKorea, Republic of, China, Spain, Taiwan, United States, Netherlands, Australia, Singapore, New Zealand, United Kingdom, Israel, France, Japan, Italy, Czechia, Belgium, Argentina, Austria, Bulgaria, Canada, Germany, Greece, Hungary, M... and more